Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition

Journal of Lipid Research

Volumn 46, Issue 1, 2005, Pages 123-134

  Sheth, Sonal S ^a   Castellani, Lawrence W ^a   Chari, Soumya ^a   Wagg, Cory ^b   Thipphavong, Christopher K ^a   Bodnar, Jackie S ^a   Tontonoz, Peter ^a   Attie, Alan D ^c   Lopaschuk, Gary D ^b   Lusis, Aldons J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Fatty acid oxidation; Hypertriglyceridemia; Hypoglycemia; Mice; Nutritional status; Redox status

Indexed keywords

ACYL COENZYME A OXIDASE; FATTY ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; KETONE BODY; NICOTINAMIDE ADENINE DINUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVATE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; THIOREDOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CONTROLLED STUDY; DIET RESTRICTION; GENE; GENE IDENTIFICATION; HYPERLIPIDEMIA; MOLECULAR CLONING; MOUSE; MUSCLE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN INTERACTION; THIOREDOXIN INTERACTING PROTEIN DEFICIENCY; THIOREDOXIN INTERACTING PROTEIN GENE; WILD TYPE;

ANIMALS; BIOLOGICAL MARKERS; BODY COMPOSITION; CARRIER PROTEINS; ENZYMES; FASTING; FEEDING BEHAVIOR; METABOLISM; MICE; MICE, KNOCKOUT; OXIDATION-REDUCTION; PHENOTYPE; THIOREDOXIN;

EID: 19944426522     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M400341-JLR200     Document Type: Article

References (36)

1. Castellani, L. W., A. Weinreb, J. Bodnar, A. M. Goto, M. Doolittle, M. Mehrabian, P. Demant, and A. J. Lusis. 1998. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nat. Genet. 18: 374-377.
2. Bodnar, J. S., A. Chatterjee, L. W. Castellani, D. A. Ross, J. Ohmen, J. Cavalcoli, C. Wu, K. M. Dains, J. Catanese, M. Chu, S. S. Sheth, K. Charugundla, P. Demant, D. B. West, P. de Jong, and A. J. Lusis. 2002. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nat. Genet. 30: 110-116.
3. Gasdaska, J. R., M. Berggren, and G. Powis. 1995. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ. 6: 1643-1650.
4. Hirota, K., M. Matsui, S. Iwata, A. Nishiyama, K. Mori, and J. Yodoi. 1997. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA. 94: 3633-3638.
5. Nakamura, H., K. Nakamura, and J. Yodoi. 1997. Redox regulation of cellular activation. Annu. Rev. Immunol. 15: 351-369.
6. Ueda, S., H. Nakamura, H. Masutani, T. Sasada, S. Yonehara, A. Takabayashi, Y. Yamaoka, and J. Yodoi. 1998. Redox regulation of caspase-3(-like) prolease activity: regulatory roles of thioredoxin and cytochrome c. J. Immunol. 161: 6689-6695.
7. Donnelly, K. L., M. R. Margosian, S. S. Sheth, A. J. Lusis, and E. J. Parks. 2004. Increased lipogenesis and fatty acid reesterification contribute to hepatic triacylglycerol stores in hyperlipidemic Txnip-/- mice. J. Nutr. 134: 1475-1480.
8. Hui, T. Y., S. S. Sheth, J. M. Diffley, D. W. Potter, A. J. Lusis, A. D. Attie, and R. A. Davis. 2004. Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals. J. Biol. Chem. 279: 24387-24393.
9. Schulze, P. C., J. Yoshioka, T. Takahashi, Z. He, G. L. King, and R. T. Lee. 2004. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J. Biol. Chem. 279: 30369-30374.
10. Demant, P., and A. A. Hart. 1986. Recombinant congenic strains - a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics. 24: 416-422.
11. Hedrick, C. C., L. W. Castellani, C. H. Warden, D. L. Puppione, and A. J. Lusis. 1993. Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice. J. Biol. Chem. 268: 20676-20682.
12. Campbell, F. M., R. Kozak, A. Wagner, J. Y. Altarejos, J. R. Dyck, D. D. Belke, D. L. Severson, D. P. Kelly, and G. D. Lopaschuk. 2002. A role for peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. J. Biol. Chem. 277: 4098-4103.
13. 14C]glycerol. J. Biol. Chem. 258: 938-945.
14. Laffitte, B. A., S. B. Joseph, R. Walczak, L. Pei, D. C. Wilpitz, J. L. Collins, and P. Tontonoz. 2001. Autoregulation of the human liver X receptor alpha promoter. Mol. Cell. Biol. 21: 7558-7568.
15. Nishiyama, A., M. Matsui, S. Iwata, K. Hirota, H. Masutani, H. Nakamura, Y. Takagi, H. Sono, Y. Gon, and J. Yodoi. 1999. Identification of thioredoxin-binding protein-2/vitamin D (3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J. Biol. Chem. 274: 21645-21650.
16. Adams, J. D., Jr., and L. K. Klaidman. 2002. Oxidative stress and nicotinamide effects on brain pyrimidine nucleotides. Recent Research and Development in Analytical Biochemistry. 2: 249-264.
17. Holmgren, A., and M. Bjornstedt. 1995. Thioredoxin and thioredoxin reductase. Methods Enzymol. 252: 199-208.
18. Randle, P. J., P. B. Garland, C. N. Hales, and E. A. Newsholme. 1963. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet. 1: 785-789.
19. Jequier, E. 1998. Effect of lipid oxidation on glucose utilization in humans. Am. J. Clin. Nutr. 67 (Suppl. 3): 527-530.
20. Yoon, J. C., P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C. R. Kahn, D. K. Granner, C. B. Newgard, and B. M. Spiegelman. 2001. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature. 413: 131-138.
21. Herzig, S., F. Long, U. S. Jhala, S. Hedrick, R. Quinn, A. Bauer, D. Rudolph, G. Schutz, C. Yoon, P. Puigserver, B. Spiegelman, and M. Montminy. 2001. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 413: 179-183.
22. Hirota, K., M. Matsui, M. Murata, Y. Takashima, F. S. Cheng, T. Itoh, K. Fukuda, and J. Yodoi. 2000. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem. Biophys. Res. Commun. 274: 177-182.
23. Attie, A. D., R. M. Krauss, M. P. Gray-Keller, A. Brownlie, M. Miyazaki, J. J. Kastelein, A. J. Lusis, A. F. Stalenhoef, J. P. Stoehr, M. R. Hayden, and J. M. Ntambi. 2002. Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J. Lipid Res. 43: 1899-1907.
24. Ntambi, J. M., M. Miyazaki, J. P. Stoehr, H. Lan, C. M. Kendziorski, B. S. Yandell, Y. Song, P. Cohen, J. M. Friedman, and A. D. Attie. 2002. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc. Natl. Acad. Sci. USA. 99: 11482-11486.
25. Hashimoto, T., W. S. Cook, C. Qi, A. V. Yeldandi, J. K. Reddy, and M. S. Rao. 2000. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J. Biol. Chem. 275: 28918-28928.
26. Puigserver, P., Z. Wu, C. W. Park, R. Graves, M. Wright, and B. M. Spiegelman. 1998. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell. 92: 829-839.
27. Green, A., J. M. Rumberger, C. A. Stuart, and M. S. Ruhoff. 2004. Stimulation of lipolysis by tumor necrosis factor-alpha in 3T3-L1 adipocytes is glucose dependent: implications for long-term regulation of lipolysis. Diabetes. 53: 74-81.
28. Rhee, J., Y. Inoue, J. C. Yoon, P. Puigserver, M. Fan, F. J. Gonzalez, and B. M. Spiegelman. 2003. Regulation of hepatic fasting response by PPARgamma coactivator-1 alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis. Proc. Natl. Acad. Sci. USA. 100: 4012-4017.
29. Puigserver, P., and B. M. Spiegelman. 2003. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24: 78-90.
30. Shalev, A., C. A. Pise-Masison, M. Radonovich, S. C. Hoffmann, B. Hirshberg, J. N. Brady, and D. M. Harlan. 2002. Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway. Endocrinology. 143: 3695-3698.
31. Hirota, T., T. Okano, K. Kokame, H. Shirotani-Ikejima, T. Miyata, and Y. Fukada. 2002. Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J. Biol. Chem. 277: 44244-44251.
32. Rutter, J., M. Reick, L. C. Wu, and S. L. McKnight. 2001. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science. 293: 510-514.
33. Ferraz, M., K. Brunaldi, C. E. Oliveira, and R. B. Bazotte. 1997. Hepatic glucose production from L-alanine is absent in perfused liver of diabetic rats. Res. Commun. Mol. Pathol. Pharmacol. 95: 147-155.
34. Fulgencio, J. P., C. Kohl, J. Girard, and J. P. Pegorier. 1996. Troglitazone inhibits fatty acid oxidation and esterification, and gluconeogenesis in isolated hepatocytes from starved rats. Diabetes. 45: 1556-1562.
35. Junn, E., S. H. Han, J. Y. Im, Y. Yang, E. W. Cho, H. D. Um, D. K. Kim, K. W. Lee, P. L. Han, S. G. Rhee, and I. Choi. 2000. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J. Immunol. 164: 6287-6295.
36. Nishinaka, Y., H. Masutani, S. I. Oka, Y. Matsuo, Y. Yamaguchi, K. Nishio, Y. Ishii, and J. Yodoi. 2004. Importin alpha 1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2 (TBP-2/VDUP1). J. Biol. Chem. 279: 37559-37565.